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Biomimetic artiﬁcial organelles with in vitro and
in vivo activity triggered by reduction in
microenvironment
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Despite tremendous efforts to develop stimuli-responsive enzyme delivery systems, their
efﬁcacy has been mostly limited to in vitro applications. Here we introduce, by using an
approach of combining biomolecules with artiﬁcial compartments, a biomimetic strategy to
create artiﬁcial organelles (AOs) as cellular implants, with endogenous stimuli-triggered
enzymatic activity. AOs are produced by inserting protein gates in the membrane of poly-
mersomes containing horseradish peroxidase enzymes selected as a model for natures own
enzymes involved in the redox homoeostasis. The inserted protein gates are engineered by
attaching molecular caps to genetically modiﬁed channel porins in order to induce redox-
responsive control of the molecular ﬂow through the membrane. AOs preserve their struc-
ture and are activated by intracellular glutathione levels in vitro. Importantly, our biomimetic
AOs are functional in vivo in zebraﬁsh embryos, which demonstrates the feasibility of using
AOs as cellular implants in living organisms. This opens new perspectives for patient-
oriented protein therapy.
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M imicking biological processes by engineering biomi-metic nanostructures represents an elegant strategyfor addressing problems in various scientiﬁc ﬁelds,
including materials science, chemistry, electronics and medi-
cine1–3. By applying a bottom-up biomimetic design (i.e.
arranging molecules at the nanoscale via self-assembly), it is
possible to combine individual biological units, known for
their sophisticated structure and activity (e.g. proteins, lipids,
DNA), with robust synthetic materials (e.g. polymers, porous
silica surfaces, nanoparticles). This serves to develop nanoscale
biomimics with enhanced properties and functionalities2,4–8
with potential for a wide range of applications (sensitive bio-
sensing, patient tailored therapeutics, detoxiﬁcation of envir-
onmental pollutants, etc.)6,9–12.
Of particular interest are two different concepts that are cur-
rently the main focus in this research ﬁeld: (i) artiﬁcial organelles
(AOs) based on an essential need to offer efﬁcient solutions for
improved therapy and diagnostics13 and (ii) protocell systems
intended to provide simple models of cells for understanding
various internal processes2,14. These concepts are complementary,
one is essential for advancing medical applications (AOs) whereas
the second concept mimics cell behaviour based on very simple
systems (protocells). Similarly, as in nature, the sizes of the
compartments are completely different: while AOs have nano-
metre range sizes, protocells reach the micrometre range. Even
though protocells represent the ﬁrst archetypes of an artiﬁcial cell,
they still inherently lack the material variety and responsiveness
found in the most basic cellular structures, and have not yet been
investigated in vivo to determine whether they preserve their
functionality. AOs are particularly attractive nanoscale biomimics
because they can provide a required compound/signal, detoxify
harmful compounds, or change cellular conditions and reactions.
AOs are based on compartmentalisation of active compounds
(enzymes, proteins, catalysts, mimics) within artiﬁcial nano-
assemblies that reach and function in the intracellular environ-
ment, and thus serve as simpliﬁed mimics of nature’s own
organelles. Various examples of systems with potential to act as
AOs have been developed based on liposomes, porous silica
nanoparticles and polymer compartments (polymersomes) in
combination with biomacromolecules13–16. However, very few
have been evaluated in vitro to assess their in situ cellular func-
tionality6,15–18, and to the best of our knowledge, none has been
assessed in vivo. In vivo functionality of such AOs is a crucial
factor that is necessary to demonstrate that the concept of AOs is
feasible in living organisms, and thus AOs can act as cellular
implants.
Notably, natural organelles have membranes, since inside cells
compartmentalisation is essential to provide conﬁned reaction
spaces for complex metabolic reactions. Therefore, an AO should
preserve the compartmentalisation as a key factor in mimicking
natural organelles. In this respect, polymer compartments, named
polymersomes, are ideal candidates for the creation of AOs,
because of their hollow spherical structure with a membrane
serving as a border for an inner cavity and their greater
mechanical stability than lipid-based compartments, i.e. lipo-
somes19,20. In addition, the chemical nature of the copolymers
provides the possibility of controlling their properties (e.g. size,
stability biocompatibility, ﬂexibility, stimuli-responsiveness)2,21.
Polymersomes have been shown to serve either as carriers for
biomolecules and mimics1,2,21,22, or more recently for develop-
ment of nanoreactors and even the generation of AOs2,6,11,23. A
key factor for supporting in situ reactions20,24 is to render the
polymersome membranes permeable for substrates and products.
An elegant approach bioinspired from the cell membrane is to
incorporate biopores and membrane proteins25–27. Selective
membrane permeability towards protons and ions is achieved by
inserting small pore forming peptides27, while membrane pro-
teins induce size-dependent cut-off permeability26,28–30 or even
mediate the diffusion of speciﬁc molecules10,31. The few reported
AOs exhibit enzymatic reactions either inside porous polymer-
somes6,16,32 or inside polymersomes equipped with channel
porins17, with the aim of emulating cellular pathways (e.g. reac-
tive oxygen species detoxiﬁcation or glucose oxidation).
Another essential factor for tuning AO functionality is a trig-
gered response to its environment, as, for example, the redox state
of the cell, which regulates various processes involved in cellular
signalling pathways33,34. While there are a few reported examples
of polymersomes with a stimuli-responsive permeable membrane
based on the incorporation of genetically or chemically modiﬁed
membrane proteins35, only two of them have served for the
design of catalytic nanocompartments36,37, and none has been
used to control reactions inside AOs. Activation of the AO by a
speciﬁc endogenous stimulus inside cells represents a challenging
step in development of functional AOs in vivo. The design of AOs
with triggered activity and the demonstration of their in vivo
functionality represent necessary steps towards the creation of cell
implants, and the provision of smart solutions for personalised
medicine by a straightforward change of the biomolecules inside
the AOs.
Here, we present a strategy for designing AOs with an in situ
enzymatic reaction that is triggered by the presence of an intra-
cellular stimulus, and demonstrate in vitro and in vivo func-
tionality. Genetically modiﬁed outer membrane protein F
(OmpF) porins were incorporated into polymersomes to induce
redox responsiveness to the membrane, and horseradish perox-
idase (HRP) simultaneously encapsulated inside their cavity to
provide a source of the AO functionality. Such AOs with func-
tionality triggered by intracellular changes represent an advance
in mimicking that of nature’s own organelles, especially those that
are involved in the redox equilibrium of the cellular homo-
eostasis. Amphiphilic block copolymers poly(2-methyloxazoline)-
block-poly(dimethylsiloxane)-block-poly(2-methyloxazoline)
(PMOXAm-PDMSn-PMOXAm) were used to self-assemble into
polymersomes, because such copolymers have already been
shown to form membranes in which biopores and membrane
proteins can be successfully inserted36–38, and to be taken up and
to be non-toxic to various cell lines17. Once inserted in the
polymersome membrane, the modiﬁed OmpF porins act as
protein gates independent of the insertion direction, i.e. orien-
tation in the membrane36,37,39,40, and trigger the in situ HRP
enzymatic reaction when a stimulus is present in the cellular
environment. HRP was selected as model enzyme, because per-
oxidases play a signiﬁcant role in the redox homoeostasis of cells
and cell apoptosis41. This strategy of providing stimuli-
responsiveness to polymersome membranes neither affects the
membrane integrity, as for stimuli-responsive synthetic mem-
branes of compartments42, nor the size and structure of the
polymersomes. Crucial steps were the evaluation of AO toxicity
and functionality in human epithelial tumour cells (HeLa cells),
and once these were established in vivo tolerability, preservation
of the AO structure, and in situ regulation of the activity of the
encapsulated enzyme in the vertebrate zebraﬁsh embryo (ZFE)
model.
Results
Bioengineering protein gates by modiﬁcation of channel por-
ins. The key factors in the design of AOs with activity triggered
by changes in environmental conditions are on-demand perme-
ability of the compartment towards enzymatic substrates/pro-
ducts and structural integrity of the polymersome, which mimics
that of natural organelles. Therefore, our biomimetic strategy
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aimed to equip PMOXA6-PDMS44-PMOXA6 polymersome
membranes with protein gates that are responsive to changes in
glutathione (GSH) concentrations in intracellular environ-
ments, while preserving the structure of the nanocompartment
(Fig. 1a).
It has been shown very recently that chemical modiﬁcations
of amino acid residues at key locations of the OmpF porin
backbone inﬂuence the translocation of substrates through the
pore in a pH-responsive manner36. Here we go one step further
by using a double mutant of OmpF37 to attach molecular caps
to genetically introduced cysteine residues that serve to block/
unblock the OmpF pore upon changes in redox potential, which
occur when the system enters the intracellular microenviron-
ment (Fig. 1b). In contrast to polymersomes with membranes
containing OmpF genetically modiﬁed to release a payload in
reductive conditions35, our system controls the overall func-
tionality of the AOs. We chose a cysteine double mutant of
OmpF (OmpF-M) because cysteine residues, replacing the
amino acids K89 and R270, were expected to form reduction-
sensitive disulphide bonds with molecules selected to serve as
molecular caps. These molecular caps remain attached in mildly
oxidising environments and block substrate diffusion through
the pore, whereas in the presence of reducing agents, such as
intracellular GSH, their cleavage restores normal passage of
small molecular weight molecules (<600 Da) through the OmpF
pores. This approach mimics pathways of metabolism regula-
tion, where proteins within the membranes of natural cell
organelles are irreversibly activated or deactivated on
demand43,44. In addition, we were interested in developing an
irreversible protein gate in order to be able to rapidly evaluate
the functionality of the organelle in vivo.
The ability of the cysteine residues of OmpF-M to form
disulphide bonds with thiol groups of small molecular weight
molecules was examined by two complementary assays, one using
a suitable spin probe (bis-(2,2,5,5-tetramethyl-3-imidazoline-1-
oxyl-4-yl) disulphide) and the second using the ﬂuorescent dye
SAMSA ﬂuorescein (SAMSA-CF) (Fig. 1c, d).
Coupling reaction of the molecular caps with the cysteine
residues of OmpF-M resulted in the formation of OmpF
conjugates (OmpF-S-S-CF for OmpF conjugated with SAMSA-
CF, and OmpF-S-S-NO for OmpF conjugated with bis-(2,2,5,5-
tetramethyl-3-imidazoline-1-oxyl-4-yl) disulphide), respectively.
Binding of the thiol reactive spin probe to the protein was
evaluated by a combination of LC-MS-MS and electron
paramagnetic resonance (EPR). Upon in-gel digestion of the
porin45, LC-MS-MS analysis of the peptide fragments indicated a
very high labelling efﬁciency of the spin probe to cysteine residues
of the OmpF-M (96 ± 4%). Standard deviation is based on three
measurements. The EPR spectrum of the bis-(2,2,5,5-tetramethyl-
3-imidazoline-1-oxyl-4-yl) disulphide in phosphate-buffered sal-
ine (PBS) at 298 K consists of an isotropic triplet pattern
(Supplementary Figure 1) with a hyperﬁne coupling aN value of
15.8 G that is similar to reported values for analogous nitroxide
probes where no aggregation was present46,47. In contrast,
OmpF-S-S-NO gave a broad anisotropic EPR spectrum with no
isotropic component, and is similar to that reported for 5-DSA in
lipid bilayers or cholesterol aqueous solutions48. This EPR
spectrum indicates hindered rotation of the nitroxide probe49
after binding to the OmpF mutant (OmpF-S-S-NO), and
demonstrates successful binding of the bis-(2,2,5,5-tetramethyl-
3-imidazoline-1-oxyl-4-yl) disulphide to the modiﬁed OmpF
mutant (Fig. 2a).
After exposure of OmpF-S-S-NO to 10 mM DTT an isotropic
EPR spectrum (aN value of 15.9 G) characteristic of the freely
rotating spin probe was observed (Fig. 2b). This clearly
demonstrates that the nitroxide spin probe that is bound to thiol
groups of the OmpF-M under oxidative conditions is cleaved in a
reductive environment.
SAMSA-CF (Thermo Fischer Scientiﬁc) was selected as a
molecular cap because its size (molecular weight 521.49 Da) was
expected to block the OmpF-M pore, and because of its ability
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Fig. 1 Engineering stimuli-responsive OmpF. a Schematic representation of modiﬁed OmpF acting as a gate in catalytic nanocompartments. b Molecular
representation of the OmpF-M cysteine mutant37. c Chemical modiﬁcation of OmpF-M cysteine mutant with the spin probe bis-(2,2,5,5-tetramethyl-3-
imidazoline-1-oxyl-4-yl) disulphide. d Chemical modiﬁcation of OmpF-M cysteine mutant with the ﬂuorophore SAMSA-CF
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03560-x ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1127 | DOI: 10.1038/s41467-018-03560-x | www.nature.com/naturecommunications 3
to form cleavable disulphide bonds50. Thus, attachment of
SAMSA-CF to OmpF-M introduces a stimuli-responsiveness to
the pore, and therefore to the polymersome membrane when
OmpF-S-S-CF is inserted. In addition, the ﬂuorescent proper-
ties of SAMSA-CF allow pore modiﬁcation to be analysed by a
combination of sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and ﬂuorescence correlation
spectroscopy (FCS).
LC-MS-MS analysis of the peptide fragments indicated a high
labelling degree of OmpF-M (81 ± 31%). In addition, a
ﬂuorescent band appeared in the SDS-PAGE gel when
SAMSA-CF was conjugated to OmpF-M, whereas the OmpF
wild type did not interact with the ﬂuorophore; this ﬂuorescent
band supports the formation of OmpF-S-S-CF (Supplementary
Figure 2). To mimic the intracellular reductive environment,
where the GSH concentration is kept at a constantly high level
(10 mM GSH) by cytosolic enzymes51, such as glutathione
reductase, we studied the behaviour of the reduction-responsive
molecular caps in a similar environment. Because of the
absence of a steady-state concentration and constant regenera-
tion of GSH, we used 30 mM GSH to mimic the intracellular
steady state of GSH. In SDS-PAGE the ﬂuorescent band
disappeared when the OmpF-S-S-CF was mixed with GSH,
indicating successful cleavage of the molecular cap under
reductive conditions (Supplementary Figure 2).
The binding of SAMSA-CF to OmpF-M cysteine residues was
also evaluated by FCS, because it allows the determination of
diffusion coefﬁcients, which are correlated to possible interactions
of the ﬂuorescent molecules with supramolecular assemblies, such
as polymersomes, liposomes and nanoparticles in the pico- to
nanomolar concentration region9,21,47–52. We compared the
molecular brightness and diffusion times of SAMSA-CF in PBS
(pH 7.4), SAMSA-CF in 1% OG PBS (pH 7.4) and SAMSA-CF
bound to OmpF (OmpF-S-S-CF) in 1% OG PBS (pH 7.4)
(Fig. 2c). A labelling efﬁciency of an average of two SAMSA-CF
molecules per monomer was calculated by comparing the
molecular brightness (counts per molecule, CPM in kHz) of
SAMSA-CF (2.2 ± 0.7 kHz) with that of protein bound to
SAMSA-CF (4.8 ± 0.6 kHz) (Fig. 2c). Standard deviations in
molecular brightness are based on individual measurements of
the same probe (n= 60). In contrast, wild-type OmpF treated
similarly to the cysteine mutant OmpF-M, did not present any
ﬂuorescence after puriﬁcation, and there was therefore no binding
of SAMSA-CF to OmpF-WT. To determine the kinetics of OmpF
pore opening, we used FCS to evaluate the cleavage of SAMSA-
CF from labelled OmpF-M upon addition of 30 mM GSH at pH
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Fig. 2 Characterisation of stimuli-responsive OmpF Panel. a EPR spectra of bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulphide-labelled
OmpF-M experimental (black) and simulated (blue) and b bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulphide-labelled OmpF-M in 1% OG
incubated with 10 mM DTT experimental (black) and simulated (blue). c Normalised FCS autocorrelation curves for SAMSA-CF in PBS (black),
SAMSA-CF in 1% OG (blue) and OmpF-S-S-CF in 1% OG (Red). Dotted line—experimental autocorrelation curves, full line—ﬁt. d SAMSA-CF release
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7.4 by FCS, and analysed the results by a two-component ﬁt. Due
to cleavage of the disulphide bonds between the dye and the
OmpF-M, the percentage of the free dye increased over time to
85 ± 9%, with a plateau after 1 h (Fig. 2d, Supplementary
Figure 3). Standard deviations in the percentage of the free dye
are based on individual measurements of the same probe (n= 60)
during a set time point.
Catalytic enzyme-polymersome nanocompartments with pro-
tein gates. The effect of different concentrations of individual
components on the functionality of the ﬁnal system has already
been reported for the insertion of OmpF wild type into
PMOXA-PDMS-PMOXA polymersomes and enzyme encap-
sulation within the inner cavity53. Here we used the optimised
conditions and adapted them for the modiﬁed OmpF and our
AOs. PMOXA6-PDMS44-PMOXA6 copolymers spontaneously
self-assembled in the presence of HRP, HRP and OmpF-S-S-
CF, or HRP and OmpF-S-S-NO, and hollow spherical com-
partments were identiﬁed by cryo-TEM (Fig. 3a, Supplementary
Figure 4). These spherical polymer assemblies were demon-
strated by light scattering to be polymersomes with: RH of 99 ±
2 nm for HRP-loaded polymersomes containing OmpF-S-S-CF,
RH of 89 ± 4 nm for polymersomes loaded with HRP and
equipped with OmpF-SH, and RH of 101 ± 1 nm for HRP-
loaded polymersomes (Supplementary Tables 1 and 2). Stan-
dard deviations were determined based on Pearson’s coefﬁcient
of the correlation function and the Guinier ﬁtted one. The
polymersome architecture was not affected by 30 mM GSH,
with structural parameters ρ (ρ= RG/RH) values in the range
0.90–0.96, which conﬁrmed a hollow sphere morphology54
(Supplementary Tables 1 and 2). HRP-loaded polymersomes,
HRP-loaded polymersomes equipped with OmpF-SH, and
HRP-loaded polymersomes equipped with OmpF-S-S-CF all
preserved their size and did not aggregate after 2 weeks storage
at 4 °C in the dark (Supplementary Figures 5–7).
Insertion of channel proteins into enzyme-loaded PMOXA6-
PDMS44-PMOXA6 polymersomes is critical for in situ activity of
the encapsulated enzyme, because the channels allow substrates
and products of the enzymatic reaction to pass through the
membrane. As OmpF is a pore protein, its functionality is
independent of its orientation inside the membrane, and the
channel porin mediates the ﬂow of molecules up to 600 Da.
We evaluated OmpF-S-S-CF and OmpF-S-S-NO insertion
into the polymersome membrane using FCS and EPR,
respectively. A diffusion time of τd= 2573 ± 960 µs was obtained
by FCS for polymersomes with reconstituted OmpF-S-S-CF,
indicating that the modiﬁed protein gates were successfully
inserted into the polymer membranes (free OmpF-S-S-CF in 1%
OG has τd= 588 ± 261 µs). Standard deviation of the diffusion
times is acquired from individual measurements (n= 60). By
comparing the molecular brightness of the free ﬂuorophore
(CPM= 2.2 ± 0.7 kHz) and the OmpF-S-S-CF equipped poly-
mersomes (CPM= 18.9 ± 11.1 kHz), it was calculated that there
were ﬁve OmpF-S-S-CF porins/polymersome; these values are
similar to those reported previously for wild-type OmpF36
(Fig. 3b).
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Fig. 3 Characterisation of stimuli-responsive catalytic nanocompartments. a Cryo-TEM micrographs of: (left) polymersomes loaded with HRP and
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spectrum of bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulphide-labelled OmpF reconstituted in PMOXA-PDMS-PMOXA polymersomes (black
line). c Right panel: bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulphide-labelled OmpF reconstituted in PMOXA-PDMS-PMOXA polymersomes
and incubated with 10 mM DTT experimental (black line) and simulated (blue line). d Amplex Ultra Red conversion of HRP-loaded polymersomes:
immediately after addition of 30mM GSH (left), and 1 h after addition of 30mM GSH (right). OmpF-S-S-CF equipped HRP-loaded polymersomes (green)
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HRP-loaded polymersomes containing OmpF-S-S-NO pro-
duced a broad EPR spectrum (Fig. 3c), indicative of low mobility,
a result similar to that reported for 5-DSA and 16-DSA inserted
in polymersomes membranes55. However, when these HRP-
loaded polymersomes containing OmpF-S-S-NO were exposed to
reductive conditions (10 mM DTT), an isotropic EPR spectrum
(aN= 15.9 G) was observed superimposed on the broad peak,
indicating successful cleavage of some of the nitroxide spin probe
from the OmpF (Fig. 3c).
Stimuli-responsiveness of the catalytic nanocompartments. The
effect of an external stimulus on the functionality of the HRP-
loaded polymersomes equipped with OmpF-S-S-CF was eval-
uated by their response to the addition of 30 mM GSH. The
ﬂuorescent signal associated with formation of a resoruﬁn-like
product (RLP) during the in situ enzymatic reaction in the pre-
sence of Amplex Ultra Red (AR) as a substrate for HRP was
measured spectroscopically56. Enzymatic turnover of the AR
substrate was signiﬁcantly lower with HRP-loaded polymersomes
equipped with OmpF-S-S-CF (by up to 36±4%) compared to
HRP-loaded polymersomes equipped with OmpF-SH, suggesting
that the molecular cap is sufﬁcient to reduce the passage of small
molecules through the pore. Note that the very low activity of
HRP-loaded polymersomes without inserted OmpF was taken
into account for background correction. Standard deviation is
based on three measurements of separately prepared catalytic
nanocompartments. Addition of 30 mM GSH to the system
increased the activity of HRP-loaded polymersomes equipped
with OmpF-S-S-CF up to that of HRP-loaded polymersomes
equipped with OmpF-SH. This indicates that reduction of the
disulphide bridge between the attached SAMSA-CF cap and
cysteine residues of the OmpF-M successfully restored the
OmpF-M pore permeability for the substrate of the enzyme by
releasing the molecular cap (Fig. 3d, Supplementary Figures 8
and 9).
Nanocompartments as stimuli-responsive AOs. Here we have
gone a step further by developing stimulus-triggered AOs, whose
functionality is modulated by the responsiveness of modiﬁed
OmpF porins inserted in the membrane of the catalytic nano-
compartments. Previously designed AOs successfully overcame
the ﬁrst barrier of cell membranes and escaped from endo-
somes17. As PMOXA-PDMS-PMOXA polymersomes are stable
at acidic pH27,36, we consider that this will favour a successful
lysosomal/endosomal escape during the recycling of lysosomes
and endosomes.
Possible internalisation mechanisms of various PMOXA-PDMS-
PMOXA-based polymersomes and their high cytocompatibility in
various cell lines have already been reported17,57–59. Here, we
evaluated the cytocompatibility of the biomimetic AOs by testing
their cellular toxicity using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS)
assay before studying their intracellular activation and enzymatic
activity. Notably, their biocompatibility at the cellular level was
shown by the absence of any decrease in viability in HeLa cells even
after 48 h (i.e. polymer concentration ranging from 0.25 to 0.75mg
ml−1) (Supplementary Figure 10).
In order to study cellular internalisation and intracellular
localisation, we ﬁrst conjugated HRP with Atto488 (HRP-
Atto488) and Atto647 (HRP-Atto647), respectively (Supplemen-
tary Figure 11). Then we encapsulated labelled-HRP inside the
cavity of polymersomes, polymersomes equipped with OmpF-S-
S-CF, and polymersomes equipped with OmpF-SH. Cellular
uptake assays in HeLa cells indicated successful internalisation
resulting in a particulate intracellular staining pattern with
increasing intensity in a time-dependent manner from 8 to 24 h
(Fig. 4a, Supplementary Figures 12 and 13). The quantitative
analysis indicates that after 24 h AOs did not co-localise with
early endosomes or lysosomes, conﬁrming successful intracellular
endosomal escape (Supplementary Figure 14)17. Localised HRP-
Atto488 signals conﬁrmed the intracellular integrity of the
polymersomes. In sharp contrast, if cells were treated with a
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membrane disrupting agent (i.e. 0.1% saponin) (Supplementary
Figure 15), polymersome membranes were affected and resulted
in an intracellular cytoplasmic distribution of HRP-Atto488.
The capacity of the AOs to act within target cells in a stimuli-
responsive manner was investigated by using a combination of
confocal laser scanning microscopy (CLSM) and ﬂow cytometry
to evaluate their potential to respond to increased intracellular
GSH levels. HeLa cells were incubated with HRP-loaded
polymersomes without OmpF or with HRP-loaded polymer-
somes equipped with either OmpF-S-S-CF (AOs) or with
OmpF-SH. Extracellular polymersomes were removed by
washing before imaging the intracellular activity of AOs. Cells
were incubated with a 1:1 substrate mixture of H2O2 and AR to
allow the intracellular deposition, and ﬁnally conversion of AR
into its RLP by AOs. Note that both hydrogen peroxide and AR
pass through the cellular membrane via passive partitioning,
while they do not penetrate the membrane of polymersomes
(Supplementary Figure 9). In contrast to untreated cells, or
those incubated with HRP-loaded polymersomes without
OmpF, a signiﬁcant increase of intracellular ﬂuorescence was
observed with AOs equipped with OmpF-S-S-CF or OmpF-SH
(Fig. 4b, Supplementary Figure 16). A similar trend was
observed when AR turnover was quantiﬁed by ﬂow cytometry
(Supplementary Figure 17). The strong ﬂuorescent signal for
AOs based on HRP-loaded polymersomes equipped with
OmpF-S-S-CF conﬁrmed successful intracellular cleavage of
the molecular cap attached to OmpF-M, and subsequent
activation of the AOs within the intracellular environment of
the HeLa cells (Supplementary Figure 17).
In vivo activity of stimuli-responsive AOs. As a step further to
obtaining insight into their safety, tolerability and performance
in vivo, AOs were studied in a ZFE model. ZFEs were selected,
because of their recognition as a complementary vertebrate
animal model for applications, such as compound screening in
drug discovery, toxicological studies and recombinant disease
models60–62. Compared to rodent in vivo models, the ZFE
offers unique advantages: (i) high reproducibility, (ii) low costs,
(iii) high level of genetic homology to humans, (iv) availability
of transgenic lines and (v) most importantly for the evaluation
of AO, optical transparency. Due to their optical transparency,
ZFE provide the possibility of imaging ﬂuorescently-tagged
objects and ﬂuorescent processes in vivo at a high resolution
over time63 (Supplementary Figure 18). Our approach offers
the possibility of gaining detailed insight into the circulation
behaviour of AOs and subsequent enzymatic reactions as we
reported recently for nano-particulate drug delivery systems
in vivo64. In order to follow the biodistribution of AOs, we
injected intravenously via the duct of Cuvier HRP-Atto488-
loaded polymersomes with membranes equipped with OmpF-
S-S-CF or with OmpF-SH, respectively. No acute toxicity, such
as change in behaviour i.e. mobility, seizures, heart failure or
other toxic effects such as malformations, denaturation of tissue
ﬂuids or yolk mass was observed in ZFE injected with AOs after
24 h. ZFE analysed 2 h post intravenous injection of all types of
AOs containing Atto488 conjugated HRP showed a distinct
ﬂuorescent staining pattern (Supplementary Figure 19) in the
posterior cardinal vein region, and we hypothesise that poly-
mersomes are recognised by the ZFE early immune system and
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are subsequently taken up by macrophages65. The remarkable
recognition of polymersome-based AOs by the ZFE immune
system was conﬁrmed by the colocalisation of AOs loaded with
Atto647-conjugated HRP (Atto647-HRP) injected into trans-
genic ZFE speciﬁcally expressing eGFP in macrophages (Fig. 5a,
Supplementary Figure 20). In strong contrast to AOs loaded
with Atto647-HRP, the free Atto647-HRP enzyme did not show
signiﬁcant macrophage colocalisation after 24 h, even when
Atto647-HRP was injected at concentrations of 0.2 mg ml−1
(Supplementary Figure 21). Notably, only macrophages in cir-
culation were targeted and not tissue resident macrophages (i.e.
star shaped).
Once cellular internalisation of AOs by the early immune
system of ZFE was successful in vivo, we explored the uptake
rate, exact intracellular localisation and internalisation mechan-
isms of AOs in immune cells in vitro by using human
macrophage differentiated THP-1 cells. AOs internalisation
started as early as 30 min, and a strong internalisation by
immune cells was achieved after 3 h (Supplementary Figure 22),
with increasing uptake rates at higher time points. As THP-1
cells are immature macrophages with reduced phagocytotic
capacity, a higher uptake rate of AOs is possible for mature
(primary) macrophages in vitro and in vivo.66 Importantly, all
macrophage uptake studies were performed in the presence of
serum proteins to mimic physiological conditions in vivo
because opsonisation of nanoparticles by serum proteins can
highly inﬂuence their interaction with cells.67 To obtain a
mechanistic understanding of the internalisation process, THP-
1 macrophages were pre-treated with different pharmacological
pathway inhibitors.67 We used inhibitors with speciﬁc inhibi-
tion proﬁles: (i) polyinosinic acid to block scavenger receptors,
(ii) colchicine to inhibit pinocytosis, (iii) cytochalasin B as
phagocytosis inhibitor and (iv) sodium azide to inhibit all
energy-dependent uptake processes. Cells not incubated with
Atto488 HRP-loaded AOs served as a control. A 1.28-fold
increase in the mean ﬂuorescence intensity (MFI) was observed
by ﬂow cytometry analysis of the cells incubated with Atto488
HRP-loaded AOs for 6 h, which indicates internalisation of
AOs by THP-1 macrophages. The uptake of AOs by macro-
phages was signiﬁcantly inhibited by cytochalasin B (a 0.13-fold
increase in MFI) and in a lower degree by sodium azide (0.43-
fold increase in MFI), which indicates an energy-dependent
phagocytotic internalisation process (Fig. 5b, c). On the
contrary, polyinosinic acid did not inhibit the AOs uptake,
suggesting little or no involvement of the scavenger receptor in
the internalisation mechanism of AOs (Fig. 5c).
The internalisation process analysed by CLSM using Lyso-
Tracker™ Red DND-99 as a reporter for the lysosomal compart-
ments indicates that AOs co-localise with lysosomal
compartments during their internalisation process (Supplemen-
tary Figure 23). Interestingly, we could not detect a lysosome
signal (lysotracker) 24 h after incubation of macrophages with
AOs, suggesting the presence of an intracellular lysosomal escape
mechanism once the AOs are taken-up by macrophages
(Supplementary Figure 23). After internalisation in macrophages,
the signals associated with Atto488-HRP-loaded AOs in lysoso-
mal compartments changed to larger intracellular vesicular
signals. This suggests an expansion of the AO-bearing lysosomal
compartments before the AOs are released into the cytosol. For
an exact mechanism by which AOs escape the lysosomal
compartment and interact with cellular membranes, further
investigations are planned but they are beyond the scope of this
study.
In order to assess in vivo stability, integrity and functionality of
AOs when exposed to the conditions in the macrophage
microenvironment, we performed a second injection of AOs
together with the enzyme substrate AR. Injection of the co-
substrate H2O2 in combination with AR was not necessary, since
macrophages have the ability to produce H2O2. In addition, co-
injection of H2O2 resulted in a red colouring of the whole blood
volume, presumably due to haemolysis and thus interaction of
AR with erythrocyte enzymes or haemoglobin66 (Supplementary
Figure 24). Distinct colocalisation within macrophages of the
converted AR oxidation product was found only for HRP-
Atto488-loaded AOs equipped with either OmpF-SH or OmpF-S-
S-CF: the molecular cap of OmpF-S-S-CF was cleaved in vivo
leading to activation of the AOs. In sharp contrast, HRP-Atto488-
loaded polymersomes without OmpF remained inactive, demon-
strating that the polymersome membrane is sufﬁciently robust to
remain intact in ZFE macrophages (Fig. 5d).
Discussion
Design and development of AOs able to function inside cells and
support the natural organelles is a necessary step towards the
creation of cellular implants. Complementary as a concept to that
of protocells, AOs respond to an essential need to offer efﬁcient
solutions for improved therapeutic and diagnostic options. Pre-
viously reported examples of AOs were based on conﬁned spaces
for reactions by compartmentalisation of enzymes inside nanos-
cale assemblies, but were not able to function in a stimuli-
responsive manner. Here, we introduce a strategy to develop AOs
with functionality that can be switched on by changes in the
cellular microenvironment. These stimuli-responsive AOs are
created by simultaneous encapsulation of an enzyme involved in
the cellular redox homoeostasis and insertion of a genetically
engineered channel porin to serve as a protein gate that triggers
the enzymatic activity inside AOs.
Our AOs preserved their architecture and were activated after
reaching the cellular microenvironment. More exciting, they are
functional in a vertebrate ZFE model, which proves that the
concept of AOs as cellular implants is feasible in vivo. Further-
more, stability, biocompatibility and low toxicity of AOs repre-
sent real advantages for medical applications compared to
existing solutions for enzyme replacement, such as direct enzyme
delivery and transfection67.
We believe that in the future, the high versatility of our strategy
will allow straightforward development of a large variety of AOs
for speciﬁc medical applications by changing the encapsulated
enzymes and/or of the stimuli-responsive property of the protein
gates. However, a careful selection of substrates is required to
overcome the limited ability to transit through the plasma
membrane of speciﬁc substrates, which are commonly used in
bulk enzymatic reactions.
This example of AOs activated by changes in cellular micro-
environment and that remains functional in vivo, opens the
perspective of complex in situ reactions inside AOs, and repre-
sents an important advance towards the generation of multi-
functional systems that will support the development of
personalised medicine.
Methods
OmpF expression and extraction. The OmpF K89 R270 cysteine mutant and the
OmpF wild type were expressed in BL21 (DE3) Omp8 Escherichia coli cells;
detailed procedure is described in Supplementary Methods.42 The extracted frac-
tion was analysed by a 4–15% Mini-PROTEAN® TGX™ Precast SDS (Bio-Rad
Laboratories, USA) gel to conﬁrm the protein purity and the protein concentration
was determined using a BCA assay kit (Pierce Chemical Co, Rockford, USA).
OmpF was stored at 4 °C in 3% OG at a concentration of 1.2 mgml−1 for several
weeks.
OmpF modiﬁcation with SAMSA ﬂuorescein (OmpF-S-S-CF). The OmpF K89
R270 double cysteine mutant was modiﬁed by disulphide binding of SAMSA
ﬂuorescein to the free cysteine residues. The same reaction was also performed in
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the presence of OmpF wild type in 3% octyl-glucopyranoside (OG) (Anatrace,
USA) and 3% OG in order to serve as controls. Twenty microlitres of 959 µM
SAMSA-CF (5-((2-(and-3)-S-(acetylmercapto) succinoyl) amino) ﬂuorescein)
(Thermo Fischer Scientiﬁc) dissolved in 5% DMSO, 1% OG in PBS buffer was
added to 400 µl of 0.4 mg ml−1 OmpF. The mixture was shaken in dark conditions
for 30 min, when deprotection of SAMSA-CF was initiated by adjusting the pH of
the solution to 8.5 with 0.5 M NaOH. The reaction mixture was incubated and
shaken in the absence of light for 24 h at room temperature, after which another 5
µl of 959 µM SAMA ﬂuorescein was added. Twenty-four hours after the second
addition of SAMSA ﬂuorescein the protein was puriﬁed from the reaction mixture
by washing 25 times with 1% OG in PBS pH 7.4 in Amicon Ultra-0.5 ml centrifugal
ﬁlters for protein puriﬁcation and concentration, molecular cut-off: 30 kDA
(Millipore) (10 min at 13,000 RPM). The volume was adjusted to 475 µl with PBS
pH 7.4, and the protein concentration was determined by UV-Vis spectroscopy.
Forty microlitres of the puriﬁed protein fraction was taken for FCS analysis and
SDS gel electrophoresis. The volume was adjusted to 500 µl and the protein was
dialysed against 1 l of 0.05 % OG in PBS for 16 h and twice against PBS for 2 h
using 14 kDa Membra-CelTM (Carl Roth, Germany) dialysis membranes. The
protein concentration was veriﬁed by UV-VIS (A280) (Thermo Fischer Scientiﬁc,
Switzerland).
OmpF modiﬁcation with (bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl)
disulphide) (OmpF-S-S-NO*). The OmpF K89 R270 double cysteine mutant was
modiﬁed by disulphide binding of (bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-
4-yl) disulphide) (Noxygen, Germany) to the free cysteine residues. The same
reaction was also done in presence of OmpF wild type in 3% OG PBS and 3% OG
PBS in order to serve as controls for unspeciﬁc binding of (bis-(2,2,5,5-tetramethyl-
3-imidazoline-1-oxyl-4-yl) disulphide) to wild-type OmpF and unspeciﬁc inter-
actions with OG micelles. Twenty microlitres of dissolved (bis-(2,2,5,5-tetramethyl-
3-imidazoline-1-oxyl-4-yl) disulphide) (1.4 mM) in 4% DMSO, 1% OG in PBS
buffer were added to 400 µl of 0.4 mg ml−1 OmpF and mixed. The reaction was
performed as described above for OmpF-S-S-CF. Twenty-four hours after the
second addition of (bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulphide)
the conjugated protein was puriﬁed from the reaction mixture by washing it 25
times with 1% OG in PBS at pH 7.4 using Amicon Ultra-0.5 ml centrifugal ﬁlters
for protein puriﬁcation and concentration; molecular cut-off: 30kDA (Millipore).
The volume was adjusted to 475 µl using PBS at pH 7.4, and the protein con-
centration was determined by UV-Vis spectroscopy. Forty microlitres of the pur-
iﬁed protein fraction was taken for EPR analysis. The volume was adjusted to 500
µl and the protein dialysed against 1 l of 0.05 % OG in PBS for 16 h and twice
against PBS for 2 h using 14 kDa Membra-CelTM (Carl Roth, Germany) dialysis
membranes. The protein concentration was veriﬁed by UV–VIS (A280) (Thermo
Fischer Scientiﬁc, Switzerland).
Characterisation of SAMSA ﬂuorescein conjugated OmpF. A 4–15% Mini-
PROTEAN® TGX™ Precast SDS (Bio-Rad Laboratories, USA) gel polyacrylamide
gel was used, then samples were mixed with BN-PAGE loading buffer and 15 µl of
the ﬁnal OmpF solution was added to the gel. To show the effect of GSH, separate
probes were incubated with the loading buffer supplemented with 30 mM GSH.
The gels were run at 200 V for 45 min. (Supplementary Figure 2), and scanned
unstained and stained with Coomasie blue.
Fluorescence correlation spectroscopy. All FCS measurements were performed
using a Zeiss LSM 510-META/Confocor2 (Carl Zeiss, Jena, Germany) with an
argon laser (488 nm), and ×40 water immersion C-Apochromat Objective lens.
Measurements were performed at room temperature using a sample volume of 20
µl on a covered Lab-Tek Nunc® Lab-Tek® II chambered cover glass (Nalage Nunc
International). Measurements were recorded over 3 s, and each measurement was
repeated 60 times. The structural parameter and the diffusion time of the free dye
in PBS pH 7.4 (SAMSA-CF) were determined independently. The autocorrelation
function was calculated using a software correlator, and ﬁtted with a one com-
ponent ﬁt (LSM 510 META-ConfoCor2 System). Detailed description of the FCS
measurements and calculations are described in the Supplementary Methods.
Preparation of reduction-triggered catalytic polymersomes. To produce
reduction-triggered catalytic PMOXA-b-PDMS-b-PMOXA nanocompartments,
triblock copolymer ﬁlms with different subsets of Outer membrane protein F
(OmpF) were rehydrated with HRP. The detailed preparation technique and
control experiments are described in the Supplementary Methods.
Characterisation of catalytic nanocompartments. The size and morphology of
the stimuli-responsive catalytic nanocompartments were characterised by a com-
bination of light scattering (SLS, DLS) and cryogenic transmission electron
microscopy (Cryo-TEM). Detailed procedures are described in detail in the Sup-
plementary Methods.
Enzymatic assay. The emission ﬂuorescence intensity was determined using a LS
55 Fluorescence Spectrometer (Perkin Elmer). Samples were incubated with a ﬁnal
concentration of 30 mM GSH in PBS at pH 7.4, and the pH was kept at this value.
For the measurement, 10 µl of the samples mixed with GSH were transferred to
220 µl of the reaction mixture (4.5 µM H2O2 and 3.4 µM AR) in PBS at pH 7.4. The
reaction mixture was excited at 530 nm and the emission intensity was monitored
at 590 nm. Fluorescence was expressed as relative ﬂuorescence units and was
measured at the same instrument setting in all experiments. The detailed procedure
is described in the Supplementary Methods.
Cell toxicity assay. The [3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulphophenyl)-2H-tetrazolium (MTS) assay (Promega) was used to determine
cell viability. HeLa cells were seeded in a triplicate at a density of 2.5 × 103 cells per
well in a 96-well plate. Cells were cultured for 24 h in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) growth medium (supplemented with 10% foetal calf serum,
penicillin (100 units ml−1) and streptomycin (100 µg ml−1)). After 24 h, the
medium 100 μl aliquots containing the corresponding concentration of samples
[0.25, 0.5 and 0.75 mgml−1] were added to the cell medium. Cells incubated only
in medium served as control (100%). After 24 h of incubation 20 µl of MTS
solution was added to each well. The plates were incubated for 1 h at 37 °C, and
absorption was measured at λ= 490 nm. The quantity of formazan product as
measured by absorbance at 490 nm is directly proportional to the number of living
cells in the culture. Absorption of cells where no nanoparticles were added served
as 100%.
24 h uptake of catalytic nanocompartments. HeLa (epitheloid cervix carcinoma,
human; ATCC, CCL-2) cells were cultured at a density of 3 × 104 cells per well in
an eight-well Lab-Tek (NalgeNunc International, USA) for 24 h in DMEM growth
medium supplemented with 10% foetal calf serum, penicillin (100 units ml−1) and
streptomycin (100 µg ml−1) to allow attachment to the surface. After attachment,
the medium was removed and catalytic nanocompartments were added to a ﬁnal
polymer concentration of 0.5 mg ml−1. Cells were washed twice before being
imaged at the respective time points.
Flow cytometry analysis of AO activity. HeLa (epitheloid cervix carcinoma,
human; ATCC, CCL-2) cells were seeded in a well of a 24-well plate (8 × 104 cells
per well) and cultured in DMEM containing 10% foetal calf serum, penicillin (100
units ml−1) and streptomycin (100 µg ml−1)) for 24 h at 37 °C in a humidiﬁed CO2
incubator. Then the medium was exchanged and polymersome solution was added
to a ﬁnal concentration of 0.5 mg ml−1 for another 24 h. Cells were washed three
times with PBS, trypsinised, centrifuged, washed, centrifuged and then suspended
in 1 ml PBS. AR/H2O2 was added to a ﬁnal concentration of 10 µM, and after 2 h,
ﬂow cytometry analysis was performed using a BD FACSCanto II ﬂow cytometer
(BD Bioscience, USA). Doublets were excluded using FSC and SSC detectors, single
cells were excited at 561 nm and the emission was detected in FL5 (586/15;
Resoruﬁn Channel). A total of 10,000 single cells for each sample were analysed,
and data processed using Flow Jo VX software (TreeStar, Ashland, OR).
Intracellular stability of AO. HeLa (epitheloid cervix carcinoma, human; ATCC,
CCL-2) cells were seeded at a density of 3 × 104 cells ml−1 onto poly-D-lysine-
coated glass coverslips. Cells were cultured for 24 h in DMEM growth medium
(supplemented with 10% foetal calf serum, penicillin (100 units ml−1) and strep-
tomycin (100 µg ml−1)). After attachment to the surface, the medium was removed
and catalytic nanocompartments were added to a ﬁnal polymer concentration of
0.5 mg ml−1. Cells were incubated for an additional 24 h in the medium, then
washed three times with PBS and ﬁxed with 4% PFA for 15 min. After a neu-
tralisation step using 50 mM NH4Cl, cells were either treated with PBS (control) or
0.1% saponin for 10 min at room temperature. After additional washing steps, cell
nuclei were counterstained for 10 min using Hoechst 33342 (0.5 µg ml−1). Finally
cells were embedded in Vectashield antifade mounting media. CLSM was per-
formed using an Olympus FV‑1000 inverted microscope (Olympus Ltd, Tokyo,
Japan) equipped with a ×60 UPlanFL N oil‑immersion objective (numerical
aperture 1.40). Cells were excited at 405 nm (Hoechst 33342) and 488 nm
(Atto488-HRP), and the ﬂuorescence signal was collected using Kalman modus
between 425 and 475 nm and 500 and 600 nm, respectively. To minimise spectral
cross talk, the samples were scanned using sequential mode. The laser settings were
adjusted depending on the treatment. Images were processed using the Fiji open
source image processing package of ImageJ.
Intracellular localisation of AO. HeLa (epitheloid cervix carcinoma, human;
ATCC, CCL-2) cells were seeded at a density of 3 × 104 cells per well onto poly-D-
lysine-coated glass coverslips. Cells were cultured for 24 h in DMEM growth
medium (supplemented with 10% foetal calf serum, penicillin (100 units ml−1) and
streptomycin (100 µg ml−1)) to allow attachment to the surface. After attachment,
the medium was removed and catalytic nanocompartments were added to a ﬁnal
polymer concentration of 0.5 mg ml−1. After 24 h cells were washed three times
with PBS and then ﬁxed for 15 min using 4% PFA. After a neutralisation step using
50 mM NH4Cl, cells were incubated with either rabbit polyclonal anti-EEA1
(ab2900, Abcam) (1:1000) or anti-LAMP1 (ab24170, Abcam) antibody (1:1000) for
early endosome or lysosome staining, respectively58. The cells were washed with
PBS, followed by staining with the secondary goat anti-rabbit polyclonal
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Dylight633-labelled antibody (1:1000; #35562, Thermo Fisher Scientiﬁc). Cell
nuclei were counterstained for 10 min using Hoechst 33342 (0.5 µg ml−1). Finally,
cells were embedded in Vectashield antifade mounting media. CLSM was per-
formed using an Olympus FV‑1000 inverted microscope described above. Z-stacks
were taken using Kalman modus and a step size of 450 nm. Cells were excited at
405 nm (Hoechst 33342), 488 nm (Atto488-HRP), and 633 nm (Early Endosome/
Lysosome). The ﬂuorescence signal was collected between 425 and 475, 500 and
600, and 655 and 755 nm, respectively, by scanning in the sequential mode, and
processed as described above.
Colocalisation of polymersomes with markers of early endosome (EEA1) or
lysosome (LAMP1) were carried out using the JaCoP plug-in in the Fiji software.
Pearson’s correlation coefﬁcient (PCC), Mander’s coefﬁcients (M1/M2, using
thresholds of A= 200 and B= 180), and Costes’ randomisation-based
colocalisation (200 randomisation rounds) were used to assess the extent of
colocalisation.
In cellulo activity of AOs by CLSM. HeLa cells (epitheloid cervix carcinoma,
human; ATCC, CCL-2) were cultured at a density of 3 × 104 cells per well in an
eight-well Lab-Tek (NalgeNunc International, USA) for 24 h in DMEM growth
medium (supplemented with 10% foetal calf serum, penicillin (100 units ml−1)
and streptomycin (100 µg ml−1) to allow attachment to the surface. After
attachment, the medium was removed and catalytic nanocompartments were
added to a ﬁnal polymer concentration of 0.25 mg ml−1. Cells were then incu-
bated for an additional 24 h in medium, washed twice with PBS and AR/H2O2
added in the ratio of 1:1 to a ﬁnal concentration of 10 µM in DMEM-based
growth medium. After 30 min, cells were washed three times with PBS and their
nuclei counterstained for 10 min using Hoechst 33342 (0.5 µg ml−1). Cells were
washed twice with D-PBS and cultured in DMEM. CellMask Deep Red Plasma
membrane stain (0.5 µl ml−1) was added and cells were analysed after 5 min.
CLSM was performed as described in the previous section. The laser settings for
RLP, the photomultiplier tube gain and the pinhole settings were kept constant
during the analysis. Images were processed using Olympus FluoView software
(v3.1, Olympus).
In vivo activity of AOs. Standard ZFE culture medium at pH 7.4 was prepared at
ﬁnal concentrations of 5 mM sodium chloride, 0.25 mM potassium chloride, 0.5
mM magnesium sulphate, 0.15 mM potassium dihydrogen phosphate, 0.05 mM
sodium phosphate dibasic, 0.5 mM calcium chloride, 0.71 mM sodium bicarbonate
and 0.001% (w/v) methylene blue.
Collected eggs from adult ABC/TU ZFE (wild type) and EGFPs843 ZFE (GFP-
macrophage line) were kept in ZFE culture medium at 28 °C. PTU (0.03 mgml−1)
was added 1-day post fertilisation (dpf) in order to avoid pigment cell formation.
Three different enzyme-loaded polymersomes were injected into 2-dpf ZFE
according to an adapted protocol originally designed for microangiography. ZFE
were anaesthetised using 0.01% tricaine (w/v) and cast into 0.3% (w/v) agarose
containing the same amount of tricaine. Immobilised ZFE were injected with either
with 3 nl of 0.2 mg ml−1 free HRP or 3 nl AO solution (5 mgml−1), removed from
the agarose and kept in ZFE culture medium containing PTU for 24 h. Then, a
second injection of 1 nl AR (78 µM) was performed following the same procedure.
As control experiments, ZFE were injected with the enzymatic substrate AR and
AR mixed with H2O2 without previous AO injection. Fluorescence imaging of
injected ZFE was performed using an Olympus FV1000 confocal microscope
(Olympus Schweiz AG, Volketswil, Switzerland). ZFE were excited at 488 nm
(Atto488 HRP), 559 nm (Melanocytes) and 635 nm (Resazurin-like product) and
the ﬂuorescence signal was collected between 500 and 530, 575 and 620, and 655
and 755 nm, respectively.
Monocyte cell culture and differentiation to macrophages. THP-1 cells (ATCC,
TIB 202) were cultured at a starting density of 2 × 105 cells ml−1 in Roswell Park
Memorial Institute (RPMI-1640) medium containing 10% FCS, penicillin (100
units ml−1)/streptomycin (100 µg ml−1), 10 mM HEPES, 1% sodium pyruvate and
0.05 mM mercaptoethanol. For uptake studies, THP-1 cells were seeded at a
density of 5.5 × 104 cells per well onto poly-D-lysine-coated Ibidi 8-Well µ-Slides or
2 × 105 cells per ml into a 12-well plate (TPP, Switzerland) for CLSM or ﬂow
cytometry, respectively. Differentiation of human monocytic cell line THP-1 to
macrophages was induced 24 h after seeding using 200 nM phorbol 12-myristate
13-acetate for 72 h.
Uptake study using pathway inhibitors. The uptake mechanism of Atto488-
HRP-loaded polymersomes equipped with OmpF-S-S-CF into THP-1 macro-
phages was investigated using different pharmacological pathway inhibitors67. Cells
were pre-incubated using 10 µg ml−1 cytochalasin B (phagocytosis) for 2 h, 0.1%
sodium azide (energy-dependent uptake process) for 30 min, 100 µg ml−1 colchi-
cine (pinocytosis) for 2 h and 2.5 µg ml−1 polyinosinic acid (scavenger receptor) for
30 min, and then treated with Atto488-HRP-loaded polymersomes.
Qualitative uptake of AOs observed by CLSM. Macrophage differentiated THP-
1 cells were incubated with Atto488-HRP-loaded polymersomes equipped with
OmpF-S-S-CF at a ﬁnal polymer concentration of 0.25 mgml−1 for speciﬁc time
points as indicated. LysoTracker Red DND-99 (Invitrogen) was added to cells 1 h
before imaging at a concentration of 50 nM when indicated. Cell nuclei were
counterstained using Hoechst 33342 (2.5 µg ml−1). Cell membranes were stained
using CellMask Deep Red Plasma membrane stain (0.5 µl ml−1) when indicated
directly before imaging. Live cell imaging was performed as described in the pre-
vious section using an Olympus FV‑1000 inverted microscope (Olympus Ltd,
Tokyo, Japan) equipped with a ×60 UPlanFL N oil‑immersion objective (numerical
aperture 1.40). Orange colour indicated colocalisation of polymersomes with
lysosomes (LysoTracker Red DND-99).
Quantitative uptake studies by ﬂow cytometry. Differentiated THP-1 cells were
incubated with Atto488-HRP-loaded polymersomes equipped with OmpF-S-S-CF
at a ﬁnal polymer concentration of 0.25 mgml−1 for speciﬁc time points as indi-
cated, or in the presence of different pharmacological pathway inhibitors for 6 h.
Flow cytometry analysis was performed using a BD FACSCanto II ﬂow cytometer
(BD Bioscience, USA) as described in the previous section.
Ethical regulations. All procedures on live zebraﬁsh embryos (Danio rerio) were
carried out following the Swiss legislation on animal welfare.
Data availability. The data that support the ﬁndings of this study are included in
the Supplementary Information; the remaining data are available from the corre-
sponding author upon reasonable request.
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